Nihon M&A Center Holdings Full Year 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St

May 04, 2025

Nihon M&A Center Holdings (TSE:2127) Full Year 2025 Results

Key Financial Results

Revenue: JP¥44.1b (flat on FY 2024).
Net income: JP¥11.0b (up 2.1% from FY 2024).
Profit margin: 25% (in line with FY 2024).
EPS: JP¥34.54 (up from JP¥33.04 in FY 2024).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

earnings-and-revenue-growth — TSE:2127 Earnings and Revenue Growth May 4th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Nihon M&A Center Holdings EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 3.2%. Earnings per share (EPS) exceeded analyst estimates by 4.2%.

Looking ahead, revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 1.9% growth forecast for the Capital Markets industry in Japan.

Performance of the Japanese Capital Markets industry.

The company's shares are up 16% from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We've done some analysis and you can see our take on Nihon M&A Center Holdings' balance sheet.

Valuation is complex, but we're here to simplify it.

Discover if Nihon M&A Center Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.